Izotropic Implements Quality Management System For IzoView Breast CT Device Manufacturing
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers is pleased to announce that it has implemented a Quality Management System (QMS) for regulatory and manufacturing purposes. The QMS is a system of procedures and processes...
2021-11-29 2:00 AM EST
Izotropic's Breast CT Radiation Imaging Subsystem Powered on and Takes Initial Images
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers provides updates on the following: IzoView radiation imaging subsystem assembly, functionality, and installation features Formal radiation safety certification Initial phantom...
2021-11-22 2:00 AM EST
Izotropic ernennt Brust-CT-Experten zum Leiter der Abteilung Bildgebungstechnologie
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 5. November 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das eine spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für die genauere Brustkrebserkennung und -diagnose vermarktet, freut sich die Ernennung von Dr. Andrew M. Hernandez als Leiter der Abteilung Bildgebungstechnologie bekanntzugeben. Dr. Hernandez hat die letzten 8 Jahre an Design,...
2021-11-05 3:04 PM EDT
Izotropic Appoints Breast CT Expert as Head of Imaging Technology
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers is pleased to announce the appointment of Dr. Andrew M. Hernandez as Head of Imaging Technology. Dr. Hernandez has spent the last 8 years working on the design, development, and...
2021-11-05 8:00 AM EDT
Izotropic erreicht Meilensteine im 3. Quartal und gibt technisches Update
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 20. Oktober 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das die spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für eine genauere Brustkrebserkennung und -diagnose vermarktet, gibt folgende Updates bekannt: Die Meilensteine für das Q3 wurden wie geplant erreicht, einschließlich der Implementierung der Software zur 3D-Bildrekonstruktion,...
2021-10-20 2:38 PM EDT
Izotropic Reaches Q3 Milestones and Provides Engineering Update
Vancouver, British Columbia--(Newsfile Corp. - October 13, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, provides updates on the following: Q3 Milestones achieved as scheduled, including 3D imaging reconstruction software implementation, mechanical and electrical design, and...
2021-10-13 8:00 AM EDT
Izotropic unterzeichnet Vereinbarung mit der Johns Hopkins University School of Medicine zur Entwicklung von Algorithmen für maschinelles lernen für Izoview Breast-CT
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 21. September 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen zur Vermarktung der speziellen Brust-CT-Bildgebungsplattform IzoView für eine genauere Brustkrebserkennung und -diagnose, gab heute bekannt, eine Vereinbarung mit der Johns Hopkins University School of Medicine (JHU) abgeschlossen zu haben. Entwickelt werden soll dabei Bildrekonstruktionssoftware (tiefe...
2021-09-21 3:52 PM EDT
Izotropic Signs Agreement with Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT
Vancouver, British Columbia--(Newsfile Corp. - September 21, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today it has entered into an agreement with Johns Hopkins University School of Medicine (JHU) to develop image reconstruction software (deep machine learning...
2021-09-21 8:00 AM EDT
Izotropic Nominated for Best New Radiology Device Award
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today that it received a semifinalist nomination for AuntMinnie.com's 2021 award campaign to recognize the best and brightest in medical imaging. Auntminnie.com, a...
2021-09-09 8:00 AM EDT
Izotropic Receives Notice of Allowance for New 3D X-Ray Beam Filter Patent From USPTO
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today it has received a Notice of Allowance in response to a patent application from the United States Patent and Trademark Office (USPTO). The patent pertains to a...
2021-09-08 8:00 AM EDT
Izotropic Engages Consultants for Investor Relations and Dedicated Social Media and Communications Services
Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today that it has engaged Oak Hill Financial to provide financial marketing services and Mr. Tyler Muir of TMM Capital Advisory to provide social media and...
2021-09-07 9:00 AM EDT
Izotropic ernennt medizintechnischen F&E-Experten zum Executive VP für Produkttechnik
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 2. Juli 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen") ein Unternehmen, das die echte 3D dedizierte Brust-Computertomographie (CT)-Bildgebungstechnologie "Izoview" zur diagnostischen Identifizierung von Brustkrebs vermarktet, verkündete heute die Ernennung von Dr. Younes Achkire als EVP für Produkttechnik. Er wird für das endgültige Design und die Herstellung von Izoview und...
2021-07-02 2:17 PM EDT
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing "Izoview," a true 3D, dedicated Breast Computed Tomography (CT) imaging technology for the diagnostic identification of breast cancers, announced today that it has appointed Dr. Younes Achkire as EVP of Product Engineering, responsible for the final design and fabrication of Izoview and future accessory products....
2021-06-30 8:00 AM EDT
Izotropic aktualisiert Zeitplan für klinische Studien und Herstellung der ersten Izoview-Geräte
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 4. Juni 2021) - Die Izotropic Corporation ("Izotropic" oder das "Unternehmen") (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ein Unternehmen, das die echte dedizierte 3D-Brust-Computertomographie(CT)-Bildgebungstechnologie Izoview zur diagnostischen Identifizierung von Brustkrebs vermarktet, erteilt folgende aktuelle Informationen: Izoview der 5. Generation mit verbessertem Produktdesign für stärkere Leistung, bessere Benutzerfreundlichkeit,...
2021-06-04 1:57 PM EDT
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing "Izoview", a true 3D, dedicated Breast Computed Tomography (CT) imaging technology for the diagnostic identification of breast cancers, provides updates on the following: Izoview, 5th generation, enhanced product design for performance improvements, added usability, increasing competitive advantages and target market...
2021-06-03 3:07 PM EDT
Izotropic Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - May 27, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is releasing this bulletin to alert and inform shareholders of the following message from CEO, Dr. John McGraw: "On behalf of the Company, I would like to provide some assurance as to our progress and execution of our business plans. The Company has made significant strides in its commercialization plans to date and is making excellent...
2021-05-27 10:26 PM EDT
Tomosynthese-Pionier tritt dem wissenschaftlichen Beirat von Izotropic bei
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 20. April 2021) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das echte 3D-Brust-CT-Bildgebungstechnologie für die frühere Erkennung von Brustkrebs vermarktet, gibt die Bestellung von Dr. Tao Wu in seinen wissenschaftlichen Beirat bekannt. Dr. John McGraw, Präsident und CEO von Izotropic, kommentierte: "Ich freue mich sehr, Dr. Wu in unserem Beirat willkommen zu...
2021-04-20 2:41 PM EDT
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing true 3D, dedicated breast CT imaging technology for the earlier detection of breast cancers, is pleased to announce it has appointed Dr. Tao Wu to its Scientific Advisory Board. Dr. John McGraw, President and CEO of Izotropic, commented, "I am extremely pleased to welcome Dr. Wu to our Advisory Board. He is one of...
2021-04-20 9:00 AM EDT
Izotropic treibt Aktivitäten zur Zusammenarbeit mit Kostenträgern mit Excite International beschleunigt voran
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 24. März 2021) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen zur Vermarktung echter 3D-Brust-CT-Bildgebungstechnologie zur früheren Brustkrebserkennung, freut sich bekannt zu geben, dass es eine Partnerschaft mit EXCITE International (EXCITE) eingegangen ist, um die anstehende kommerzielle Einführung von IZOview vorzubereiten. EXCITE ist ein globales Netzwerk von...
2021-03-24 12:51 PM EDT
Izotropic Accelerates Payor Engagement Activities with Excite International
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing true 3D, dedicated breast CT imaging technology for the earlier detection of breast cancers, is pleased to announce it has partnered with EXCITE International (EXCITE), a global network of payors, health systems, patients, scientists, and end-users, to prepare for future commercial adoption of the IZOview. This...
2021-03-24 8:00 AM EDT